Cohen-Barak O

References (3)

Title : Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence - Gilgun-Sherki_2016_Drug.Alcohol.Depend_166_13
Author(s) : Gilgun-Sherki Y , Eliaz RE , McCann DJ , Loupe PS , Eyal E , Blatt K , Cohen-Barak O , Hallak H , Chiang N , Gyaw S
Ref : Drug Alcohol Depend , 166 :13 , 2016
Abstract :
PubMedSearch : Gilgun-Sherki_2016_Drug.Alcohol.Depend_166_13
PubMedID: 27394932

Title : Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users - Shram_2015_J.Clin.Psychopharmacol_35_396
Author(s) : Shram MJ , Cohen-Barak O , Chakraborty B , Bassan M , Schoedel KA , Hallak H , Eyal E , Weiss S , Gilgun Y , Sellers EM , Faulknor J , Spiegelstein O
Ref : J Clin Psychopharmacol , 35 :396 , 2015
Abstract :
PubMedSearch : Shram_2015_J.Clin.Psychopharmacol_35_396
PubMedID: 26082975

Title : Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects - Cohen-Barak_2015_J.Clin.Pharmacol_55_573
Author(s) : Cohen-Barak O , Wildeman J , van de Wetering J , Hettinga J , Schuilenga-Hut P , Gross A , Clark S , Bassan M , Gilgun-Sherki Y , Mendzelevski B , Spiegelstein O
Ref : Journal of Clinical Pharmacology , 55 :573 , 2015
Abstract :
PubMedSearch : Cohen-Barak_2015_J.Clin.Pharmacol_55_573
PubMedID: 25524052